41 studies found for:    ovarian cancer recurrence | Open Studies | Exclude Unknown
Show Display Options
Rank Status Study
1 Recruiting Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval
Condition: Ovarian Cancer
Interventions: Drug: stealth liposomal doxorubicin;   Drug: carboplatin;   Drug: paclitaxel;   Drug: Topotecan;   Drug: Gemcitabine
2 Recruiting Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) in Ovarian Cancer Recurrence
Condition: First Recurrence of Ovarian Cancer
Interventions: Procedure: Secondary citoreduction;   Procedure: Hyperthermic intra-peritoneal chemotherapy (HIPEC)
3 Recruiting Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer
Condition: Recurrent Ovarian Cancer
Interventions: Drug: Bevacizumab;   Drug: Paclitaxel;   Drug: Carboplatin;   Drug: pegylated liposomal doxorubicin;   Drug: Gemcitabine
4 Recruiting Whole-body Diffusion MRI for Staging, Response Prediction and Detecting Tumor Recurrence in Patients With Ovarian Cancer
Condition: Ovarian Carcinoma
Intervention: Other: Whole body diffusion-weighted MRI
5 Recruiting A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer
Conditions: Ovarian Cancer;   Malignant Female Reproductive System Neoplasm;   Cancer;   Ovarian Tumor;   Ovarian Epithelial Cancer Recurrent
Interventions: Drug: DOXIL/CAELYX;   Drug: ATI-0918
6 Recruiting Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer
Condition: Ovarian Epithelial Cancer Recurrent
Interventions: Drug: bevacizumab and trabectedin;   Drug: bevacizumab, trabectedin and carboplatin
7 Recruiting Trial of Adjuvant FANG™ Vaccine for High Risk Stage III/IV Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Biological: FANG™
8 Not yet recruiting BRCA-Screening in Ovarian Cancer
Conditions: BRCA Status;   Ovarian Cancer
Intervention: Genetic: Testing of BRCA status regarding germline and somatic mutation
9 Recruiting Prognostic and Predictive Value of HE4 Biomarker in Metastatic Ovarian Cancer
Condition: Metastatic Ovarian Cancer
Intervention: Other: Experimental arm
10 Not yet recruiting H.O.P.E: Helping Ovarian Cancer Patients Cope
Conditions: Platinum-resistant Ovarian Cancer;   Recurrent Ovarian Cancer;   Palliative Care
Interventions: Other: Structured Palliative Care;   Other: Usual Care
11 Recruiting Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
Intervention: Procedure: Tumor Debulking Surgery (surgery in recurrent ovarian disease)
12 Recruiting Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer
Intervention: Drug: BIBF 1120
13 Recruiting Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?
Conditions: Ovarian Epithelial Cancer Recurrent;   Fallopian Tube Carcinoma;   Primary Peritoneal Carcinoma
Interventions: Procedure: Secondary Cytoreductive Surgery;   Drug: Salvage Chemotherapy
14 Recruiting p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246
Condition: Platinum Sensitive Recurrent High-grade Serous Ovarian Cancer With Mutated p53
Interventions: Drug: APR-246;   Drug: Carboplatin;   Drug: Pegylated Liposomal Doxorubicin Hydrochloride (PLD)
15 Recruiting Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Procedure: ovarian cancer surgery
16 Recruiting Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: NGR-hTNF;   Drug: Pegylated liposomal doxorubicin;   Drug: Doxorubicin
17 Recruiting Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Procedure: Secondary debulking;   Procedure: secondary debulking with intraperitoneal chemotherapy
18 Recruiting Interactive Educational Website for Women With Ovarian Cancer & Caregivers
Conditions: Stage III Ovarian Cancer;   Stage IV Ovarian Cancer;   Recurrent Ovarian Cancer;   Fallopian Tube Cancer
Interventions: Behavioral: Usual Care Educational Website;   Behavioral: Prototype System
19 Recruiting Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma
Conditions: Ovarian Cancer;   Adverse Effects
Intervention: Drug: Sunitinib
20 Recruiting A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid Tumors
Conditions: Breast Cancer;   Ovarian Cancer;   Colon Cancer;   Lung Cancer;   Gastric Cancer;   Solid Tumors
Interventions: Drug: Veliparib (ABT-888);   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years